Impact of family history of breast cancer on tumour characteristics, treatment, risk of second cancer and survival among men with breast cancer

Swiss Medical Weekly

Volumn 143, Issue , 2013, Pages

  Bouchardy, Christine ^a   Rapiti, Elisabetta ^a   Fioretta, Gerald ^a   Schubert, Hyma ^a   Chappuis, Pierre ^b   Vlastos, Georges ^b   Benhamou, Simone ^a,c  

^a GENEVA CANCER REGISTRY   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c INSERM   (France)

Author keywords

Breast cancer; Breast neoplasms; Epidemiology; Familial; Male; Neoplasms; Second primary; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADULT; AGED; ARTICLE; AWARENESS; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILY HISTORY; HIGH RISK PATIENT; HUMAN; LUNG CANCER; MALE; MALE BREAST CANCER; MASTECTOMY; MULTIMODALITY CANCER THERAPY; OVARY CANCER; OVERALL SURVIVAL; PROSTATE CANCER; SECOND CANCER; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; TONGUE CANCER; BREAST TUMOR; FEMALE; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; OVARY TUMOR; PAGET NIPPLE DISEASE; PROGNOSIS; RADIOTHERAPY; REGISTER; RISK FACTOR; SURVIVAL RATE; SWITZERLAND; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OVARIAN NEOPLASMS; PROGNOSIS; RADIOTHERAPY; REGISTRIES; RISK FACTORS; SURVIVAL RATE; SWITZERLAND;

EID: 84887986234     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2013.13879     Document Type: Article

References (22)

1. Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet. 2006;367(9510):595-604.
2. Johansen Taber KA, Morisy LR, Osbahr AJ, III, Dickinson BD. Male breast cancer: risk factors, diagnosis, and management (Review). Oncol Rep. 2010;24(5):1115-20.
3. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, et al. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet. 1997;60(2):313-9.
4. Ewertz M, Holmberg L, Tretli S, Pedersen BV, Kristensen A. Risk factors for male breast cancer - a case-control study from Scandinavia. Acta Oncol. 2001;40(4):467-71.
5. Rosenblatt KA, Thomas DB, McTiernan A, Austin MA, Stalsberg H, Stemhagen A, et al. Breast cancer in men: aspects of familial aggregation. J Natl Cancer Inst. 1991;83(12):849-54.
6. Hartman M, Hall P, Edgren G, Reilly M, Lindstrom L, Lichtenstein P, et al. Breast cancer onset in twins and women with bilateral disease. J Clin Oncol. 2008;26(25):4086-91.
7. Auvinen A, Curtis RE, Ron E. Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst. 2002;94(17):1330-2.
8. Bagchi S. Men with breast cancer have high risk of second cancer. LancetOncol. 2007;8(3):198.
9. Grenader T, Goldberg A, Shavit L. Second cancers in patients with male breast cancer: a literature review. J Cancer Surviv. 2008;2(2):73-8.
10. Hemminki K, Granstrom C. Re: Risk of subsequent cancer following breast cancer in men. J Natl Cancer Inst. 2002;94(24):1892.
11. Wernberg JA, Yap J, Murekeyisoni C, Mashtare T, Wilding GE, Kulkarni SA. Multiple primary tumors in men with breast cancer diagnoses: a SEER database review. J Surg Oncol. 2009;99(1):16-9.
12. Bouchardy C. Switzerland, Geneva. In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M et al., editors. Cancer Incidence in Five Continents Vol. IX. Lyon: International Agency for Research on Cancer; 2007. p. 369-70.
13. ICD-O International classification of diseases for oncology. 3 ed. Geneva: World Health Organization (WHO); 2000.
14. Verkooijen HM, Fioretta G, Chappuis PO, Vlastos G, Sappino AP, Benhamou S, et al. Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Ann Oncol. 2004;15(2):350-3.
15. Verkooijen HM, Chappuis PO, Rapiti E, Vlastos G, Fioretta G, Sarp S, et al. Impact of familial risk factors on management and survival of early-onset breast cancer: a population-based study. Br J Cancer. 2006;94(2):231-8.
16. TNM Classification of Malignant Tumours. 6 ed. New York: John Wiley & Sons; International Union Against Cancer (UICC); 2002.
17. Statistical Methods in Cancer Research - Volume II - The Design and Analysis of Cohort Studies. Breslow NE & Day NE, eds. IARC Scientific Publications No. 82, 1987.
18. Miao H, Verkooijen HM, Chia KS, Bouchardy C, Pukkala E, Laronningen S, et al. Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol. 2011;29(33):4381-6.
19. Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer. 2004;101(1):51-7.
20. Kiluk JV, Lee MC, Park CK, Meade T, Minton S, Harris E, et al. Male breast cancer: management and follow-up recommendations. BreastJ. 2011;17(5):503-9.
21. Cutuli B, Le Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, et al. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol. 2010;73(3):246-54.
22. Hill A, Yagmur Y, Tran KN, Bolton JS, Robson M, Borgen PI. Localized male breast carcinoma and family history. An analysis of 142 patients. Cancer. 1999;86(5):821-5.